相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略:5 种常见类型+关键误区Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
PF-04457845
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥610.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥550.0 |
| 规格: | 10 mg | 产品价格: | ¥950.0 |
| 规格: | 25 mg | 产品价格: | ¥2000.0 |
| 规格: | 50 mg | 产品价格: | ¥3000.0 |
| 规格: | 100 mg | 产品价格: | ¥5400.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Redafamdastat
CAS No. : 1020315-31-4
MCE 国际站:Redafamdastat
产品活性:Redafamdastat (PF-04457845) 是一种高效选择性的 FAAH 抑制剂,作用于 hFAAH 和 rFAAH,IC50 分别为 7.2±0.63 nM 和 7.4±0.62 nM。是是
研究领域:Metabolic Enzyme/Protease | Neuronal Signaling | Autophagy
In Vitro: Redafamdastat inhibits FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1s-1 and 7.2 nM, respectively, for human FAAH). Redafamdastat has exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling. Redafamdastat completely inhibits FAAH in human and mouse membrane proteomes at both 10 and 100 μM with no off targets. Redafamdastat is completely selective for FAAH, and none of the other FP-reactive serine hydrolases in the tested tissues are inhibited by Redafamdastat even at 100 μM.
In Vivo: Oral administration of Redafamdastat at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain. Oral administration of Redafamdastat causes a significant inhibition of mechanical allodynia measured after 4 h with a minimum effective dose (MED) of 0.1 mg/kg. Furthermore, at 0.1 mg/kg (p.o.), Redafamdastat inhibits the pain response to a comparable degree as the nonsteroidal anti-inflammatory drug naproxen at 10 mg/kg. FAAH is confirmed to be completely inhibited in mice treated with Redafamdastat at 1 and 10 mg/kg p.o. by competitive activity-based protein profiling (ABPP) study.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Metabolism/Protease Compound Library | Neuronal Signaling Compound Library | Clinical Compound Library | Autophagy Compound Library | Drug Repurposing Compound Library | Chemical Probe Library | Lipid Metabolism Compound Library | Human Metabolite Library | Pain-Related Compound Library | Highly Selective Inhibitors Library | Cell Death Library | Carprofen | Biochanin A | JZL195 | MAGL-IN-5 | URB-597 | PF-3845 | BIA 10-2474 | JNJ-1661010 | FAAH-IN-2 | LY2183240 | AA38-3 | JNJ-42165279 | URB937 | 1-Monomyristin | AM 374 | FP-Biotin | N-Arachidonoylserotonin | N-Benzylpalmitamide | N-Benzyllinolenamide | SA 47 | SSR411298 | TC-F2 | VU534 | AM1172 | Carpro-AM1 | CB2R/FAAH modulator-1 | CB2R/FAAH modulator-2 | CB2R/FAAH modulator-3
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料


















